All COVID19 articles
-
PHE/DH/DWP guidelinePHE management of patient/staff exposure to COVID-19
This summary provides guidance on the management of staff and patients according to exposures, symptoms, and test results
-
PHE/DH/DWP guideline
NHS England COVID-19 vaccination SOP
This standard operating procedure (SOP) summary describes the operating model and design requirements for safe delivery of COVID-19 vaccines in the community
-
Information
Key COVID-19 guidance for primary care
The Guidelines team has produced the following directory of COVID-19 information and guidance for primary care. Included on this page is a collection of key guidance and advice from PHE and the NHS, as well as a list of information for specific groups from a range of professional bodies.
-
News
COVID-19 vaccinations to be delivered by high street pharmacies from today
As the NHS accelerates its largest vaccination programme to date, high street pharmacies have begun delivering protective COVID-19 vaccinations
-
PHE/DH/DWP guideline
PHE COVID-19 vaccination guidance
A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme
-
NICE guideline
NICE ‘long COVID’ guideline
Recommendations for identifying and managing ‘long-COVID’ in primary care
-
NHS guideline
NHS England COVID-19 guidance for community pharmacy
This standard operating procedure summary sets out general principles for the delivery of services during the COVID-19 pandemic, and requires local interpretation
-
NICE guideline
COVID-19 rapid guideline: managing COVID-19 symptoms in the community
The purpose of this guideline is to provide recommendations for managing COVID‑19 symptoms for patients in the community, including at the end of life. It also includes recommendations about managing medicines for these patients, and protecting staff from infection
-
NICE guideline
COVID-19 rapid guideline: cystic fibrosis
The purpose of this Guidelines summary is to maximise the safety of patients with cystic fibrosis and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match capacity to patient needs if services become limited because of the COVID-19 pandemic.
-
PHE/DH/DWP guideline
PHE COVID-19 infection prevention and control guidance
Summary of the latest UK guidance on infection prevention and control measures for COVID-19.
-
NHS guideline
NHS video consulting guideline
This Guidelines summary covers guidance for safe video consulting in general practice during the COVID-19 pandemic
-
NICE guideline
COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response
The purpose of this guideline is to maximise the safety of children and adults who have gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
-
Independent professional body guideline
PCWHF HRT provision during COVID-19 guidance
This summary is intended to aid primary healthcare practitioners in initiating, reviewing, and prescribing hormone replacement therapy for women during COVID-19.
-
NICE guideline
COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders
The purpose of this guideline is to maximise the safety of children and adults with rheumatological autoimmune, inflammatory and metabolic bone disorders during the COVID-19 pandemic, while protecting staff from infection. It also enables services to make the best use of NHS resources
-
NICE guideline
COVID-19 rapid guideline: chronic kidney disease
This COVID-19 rapid guideline aims to maximise the safety of adults with chronic kidney disease during the COVID-19 pandemic. It also aims to protect staff from infection and enable services to make the best use of NHS resources.
-
NICE guideline
COVID-19 rapid guideline: dermatological conditions treated with drugs affecting the immune response
The purpose of this Guidelines summary is to maximise the safety of children and adults who have dermatological conditions treated with drugs affecting the immune response during the COVID-19 pandemic.
-
NICE guideline
COVID-19 rapid guideline: pneumonia in adults
The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic.
-
NICE guideline
COVID-19 rapid guideline: community-based care of patients with chronic obstructive pulmonary disease (COPD)
The purpose of this summary is to maximise the safety of patients with chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources. For more detailed information, please refer to the full guideline.
-
NICE guideline
COVID-19 rapid guideline: severe asthma
The purpose of this guideline is to maximise the safety of adults and children with severe asthma during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.
